One patient with a history of trabeculectomy with Mitomicin C 0.02%, but no history of systemic disorders, exhibited unilateral corneal lipid infiltrates, together with deep stromal vascularization. She was treated with a bevacizumab injection and penetrating keratoplasty. No sign of recurrence was noted after one year post-operative.
Lipid corneal degeneration after trabeculectomy with mitomicin 0.02%
StivalLRS, ChavesLFOB, SauterK, BenizLAF, SoaresJSB, RodriguesFW, ToledoMC, et al. Lipid corneal degeneration after trabeculectomy with mitomicin 0.02%. Rev Bras Oftalmol. 2016;75(6):470-2.
Stival,Larissa Rossana Souza; Chaves,Luis Fernando Oliveira Borges; Sauter,Karine; Beniz,Luiz Arthur Franco; Soares,Jordana Sandes Barbosa; Rodrigues,Francisco Wellington; Toledo,Marcia Cristina; Beniz,José. Lipid corneal degeneration after trabeculectomy with mitomicin 0.02%. Rev Bras Oftalmol., v. 75, n. 6, p. 470-472, Dec. 2016.
Stival,L.R.S., Chaves,L.F.O.B., Sauter,K., Beniz,L.A.F., Soares,J.S.B., Rodrigues,F.W., Toledo,M.C., & Beniz,J. (2016). Lipid corneal degeneration after trabeculectomy with mitomicin 0.02%. Rev Bras Oftalmol.,75(6), 470-472.
Stival,Larissa Rossana Souza and Chaves,Luis Fernando Oliveira Borges and Sauter,Karine and Beniz,Luiz Arthur Franco and Soares,Jordana Sandes Barbosa and Rodrigues,Francisco Wellington and Toledo,Marcia Cristina and Beniz,José. Lipid corneal degeneration after trabeculectomy with mitomicin 0.02%. Rev Bras Oftalmol. [online]. 2016, vol. 75, n. 6, [cited 2026-03-09], pp.470-472. Available from: <https://www.rbojournal.org/en/article/lipid-corneal-degeneration-after-trabeculectomy-with-mitomicin-0-02/>. ISSN 0034-7280.
